Medindose

Medindose is a hypothetical unit of measure used in medical informatics to standardize dosing across drugs and formulations. It is envisioned as a mediator between pharmacology and health data systems, enabling more consistent comparisons of dosing information in diverse contexts.

In this concept, a medindose, abbreviated MDU, represents the amount of active pharmaceutical ingredient that yields a defined pharmacodynamic effect under specified conditions. A medindose aims to capture both dose and its clinical effect within a single, interoperable reference quantity, potentially including considerations such as route of administration and time since dosing.

A medindose record in a health information system would include fields such as drug identifier, dose value, dose unit (MDU), route of administration, formulation, patient context (age, weight, organ function), time of administration, and safety flags. The idea is to provide a structured, machine-readable representation that supports dosing decisions, pharmacometric analyses, and data exchange across platforms.

The purpose of medindose is to enable cross‑drug and cross‑formulation comparability, support dosing decisions, and improve interoperability between electronic health records, clinical decision support, pharmacometric modeling, and standards-based data exchange such as HL7 FHIR. Its successful use would depend on robust definitions of pharmacodynamic effects, clear mappings to existing dosage units, and broad consensus among clinicians, researchers, and regulators.

The term is largely fictional and appears in speculative medical informatics discussions and exploratory software projects; it is not an official standard in current clinical practice. Nonetheless, it serves as a thought exercise on how standardized dose concepts might facilitate data interoperability in the future.